Bank of Nova Scotia (BNS) is not a strong buy for a beginner, long-term investor at this time. While the company has shown strong financial performance in the latest quarter, the technical indicators suggest the stock is overbought, and recent analyst downgrades indicate concerns about its ability to outperform peers. Additionally, there are no significant positive catalysts or trading signals to support an immediate buy decision.
The stock is currently overbought with an RSI of 80.505, and the MACD histogram is positively contracting at 0.813. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the price is near resistance levels (R1: 74.768, R2: 76.281), suggesting limited upside in the short term.

Strong financial performance in Q1 2026, with revenue up 6.82% YoY, net income up 110.24% YoY, and EPS up 162.12% YoY.
Recent analyst downgrades from Canaccord and TD Securities, citing concerns about the company's ability to close the valuation gap with peers and lagging performance in key segments. No significant hedge fund or insider trading activity. No recent news or political trading data.
In Q1 2026, revenue increased to $9.84 billion (up 6.82% YoY), net income rose to $2.16 billion (up 110.24% YoY), and EPS grew to 1.73 (up 162.12% YoY). These results indicate strong growth and profitability improvements.
Recent analyst activity includes downgrades from Canaccord and TD Securities, with price targets reduced to C$110 and C$111, respectively. RBC Capital and BMO Capital raised their price targets slightly but maintained neutral ratings. Overall, analysts are cautious about the stock's ability to outperform its peers.